Bluejay Diagnostics completes Symphony cartridge manufacturing site, bolstering supply — chain resilience

Bluejay Diagnostics completed establishment of a Symphony cartridge manufacturing site, meeting a Toray license milestone ahead of the Oct. 23, 2026 deadline. The added capacity is intended to reduce supply-chain concentration risk by supporting redundant manufacturing pathways across Japan and the U.S. The step supports business continuity planning as the company prepares for regulatory submission and potential commercialization of its Symphony IL-6 test. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via (Ref. ID: 202610130630ACCESSWRNAPR_____1235016) on October 13, 2026, and is solely responsible for the information contained therein. (C)